more indications Benitec’s hep B program is up there with the best of them -
Some of the players in hepatitis B treatment market are F. Hoffmann- La Roche Ltd. (Switzerland), GlaxoSmithKline, plc. (U.K.), Bristol-Myers Squibb (U.S), Novartis AG (Switzerland), Merck and Co (U.S), Novira Therapeutics Inc. (U.S.), Johnson & Johnson (U.S.), Inovio Pharmaceuticals Inc. (U.S.), Benitec biopharma Ltd. (Australia), Gilead Sciences (U.S.), Cipla Inc. (India), and Biomics biotechnologies (China) to name a few.
- Forums
- ASX - By Stock
- BLT
- Merck & Benitec
Merck & Benitec, page-10
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)